(Q37132890)

18 August 2017

1 reference

title

Bortezomib: putting mantle cell lymphoma on death row. (English)

1 reference

18 August 2017

1 reference

Andrew W Roberts

2

0 references

author name string

Andrew H Wei

series ordinal

1

1 reference

18 August 2017

1 April 2008

1 reference

18 August 2017

1 reference

18 August 2017

49

1 reference

18 August 2017

657-658

1 reference

18 August 2017

4

1 reference

Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival

18 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F10428190801942378

Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801942378

Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801942378

The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801942378

Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801942378

Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801942378

Tumor cell-selective regulation of NOXA by c-MYC in response to proteasome inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801942378

10.1080/10428190801942378

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference

PubMed ID

18398731